HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

K905-0266

tyrosine kinase inhibitor

Also Known As:

N-cyclohexyl-N,6-dimethylthieno(2,3-d)pyrimidin-4-amine

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - K905-0266: 1

Experts

1.	Ahn, Byeong-Cheol: 1 article (11/2020)
2.	Gangadaran, Prakash: 1 article (11/2020)
3.	Gopal, Arunnehru: 1 article (11/2020)
4.	Hong, Chae Moon: 1 article (11/2020)
5.	Jeon, Yong Hyun: 1 article (11/2020)
6.	Jeong, Shin Young: 1 article (11/2020)
7.	Kalimuthu, Senthilkumar: 1 article (11/2020)
8.	Lee, Ho Won: 1 article (11/2020)
9.	Lee, Jaetae: 1 article (11/2020)
10.	Lee, Sang-Woo: 1 article (11/2020)

Related Diseases

1.	Neoplasms (Cancer) 11/01/2020 - "A new tyrosine kinase inhibitor K905-0266 inhibits proliferation and sphere formation of glioblastoma cancer cells."
2.	Glioblastoma (Glioblastoma Multiforme) 11/01/2020 - "A new tyrosine kinase inhibitor K905-0266 inhibits proliferation and sphere formation of glioblastoma cancer cells."

Related Drugs and Biologics

1.	Tyrosine Kinase Inhibitors